USGovernment-News.Com

USGovernment-News.Com

News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
Press release distribution service
Home : U.S. Government News Search Engine                          

Home > U.S. Government News > Marketplace :
Home: United State Government News
Home | News | Submit Press Release |

Risperdal Lawyers Investigating Claims of Gynecomastia (Male Breast Growth)

(USGovernment-News.Com, September 10, 2013 ) New York, NY – The attorneys working with ClassAction.org are investigating allegations that the medication Risperdal causes males, especially prepubescent boys, to develop gynecomastia, a serious side effect triggering significant breast growth. It has been alleged that the manufacturers of the drug failed to properly warn patients about this risk, which may have affected their choice in medications. The attorneys working with ClassAction.org are investigating the legitimacy of these claims and need to hear from Risperdal users who developed gynecomastia to assist in their investigation.

If you have taken Risperdal and suffered from gynecomastia, please visit ClassAction.org today and report your complaints. ClassAction.org is a website dedicated to protecting the rights of consumers and keeping them informed of product recalls and emerging litigation.

Risperdal is an anti-psychotic medication prescribed for the treatment of schizophrenia, bipolar disorder, and depression. There are a number of risks and side effects inherent to each anti-psychotic medication and federal law requires a complete list of possible side effects, as well as a black box warning to alert patients to its potentially lethal side effects, to be included on these drugs. Some men who have taken Risperdal and suffered gynecomasita, however, say they were not adequately warned of the possibility of this side effect.

Gynecomastia most commonly occurs during puberty when hormones are developing and increasing. It has been alleged that Risperidal causes an increase of the hormone prolactin, which triggers breast growth. When this hormone is too high, which is likely while younger men’s hormones are still fluctuating, breasts begin to develop. While this alleged side effect is reversible through liposuction or surgery, boys and men affected by this development may be emotionally and psychologically scarred. For more information about ClassAction.org’s investigation into Risperdal and gynecomastia, please visit http://www.classaction.org/risperdal.html today.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit ClassAction.org today for a no cost, no obligation case evaluation and information about your consumer rights.


ClassAction.org

Carl Jaeckel

8004491970

pressrelease@lawyercentral.com

Source: EmailWire.Com

Source: EmailWire.com

U.S. Governement News: Politics
  • Presidential Elections
  • Democrates
  • Congress
  • House of Representatives
  • President Obama
  • Republican Party
  • Mitt Romney
  • U.S. Senate
  • U.S. Military
  • U.S. Politics
  • Politics Video Feeds

    U.S. Government Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Governing
    Point of Beginning
    Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

    No credit cards, coupons, or promo codes required. Try it today!

    USGovernment-News.Com is a news service of GroupWeb Media LLC